Pancreatic Cancer Research

ResearcherShandong UniversityActive in the last 2 years

Zuoxing Niu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-6709-7298; OpenAlex author ID A5053506947. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2012: 1 paper · 2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 4

  1. Molecular characterization and prognostic implications of KRAS mutations in pancreatic cancer patients: insights from multi-cohort analysis. Co-author DOI 10.1038/s41698-025-01087-1↗
  2. lncRNA MALAT1, HOTTIP and PVT1 as predictors for predicting the efficacy of GEM based chemotherapy in first-line treatment of pancreatic cancer patients. Last author DOI 10.18632/oncotarget.19345↗
  3. SmacN7 enhances the sensitivity of pancreatic cancer cells to tumor necrosis factor-related apoptosis-inducing ligand or gemcitabine. Co-author DOI 10.3892/ol.2013.1285↗
  4. Phase II trial of capecitabine combined with thalidomide in second-line treatment of advanced pancreatic cancer. Co-author DOI 10.1016/j.pan.2012.09.007↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yubo Jiang · 1 shared paper, 2025 · strength 0.21
  2. Huirong Xu · 1 shared paper, 2025 · strength 0.21
  3. Shengbin Shi · 2 shared papers, 2012–2017 · strength 0.13
  4. Jing Tian · 1 shared paper, 2017 · strength 0.09
  5. Cui-Juan Wang · 1 shared paper, 2017 · strength 0.09
  6. Quan-yun Liu · 1 shared paper, 2012 · strength 0.04
  7. Meng Wang · 1 shared paper, 2012 · strength 0.04
  8. Wuyuan Zhou · 1 shared paper, 2013 · strength 0.04
  9. Sheng Li · 1 shared paper, 2013 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.